1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → (19S,23 S)-tri-tert-butyl 1-(1-(2-(bis(2-tert-butoxy-2-oxoethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(2-tert-butoxy-2-oxoethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-13,21-dioxo-2,14,20,22-tetraazapentacosane-19,23,25-tricarboxylate

HRID 1509977Notes

Reaction equation

HRID 1509977 reaction equation
[NH2:1][CH2:2][CH2:3][CH2:4][CH2:5][C@H:6]([NH:14][C:15](=[O:34])[NH:16][C@@H:17]([CH2:25][CH2:26][C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])[C:18]([O:20][C:21]([CH3:24])([CH3:23])[CH3:22])=[O:19])[C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8].[C:35]([O:39][C:40](=[O:100])[CH2:41][N:42]([CH2:92][C:93](=[O:99])[O:94][C:95]([CH3:98])([CH3:97])[CH3:96])[C:43](=[O:91])[CH2:44][N:45]1[CH:49]=[CH:48][N:47]=[C:46]1[CH2:50][N:51]([CH2:65][C:66]1[N:67]([CH2:71][C:72](=[O:90])[N:73]([CH2:82][C:83](=[O:89])[O:84][C:85]([CH3:88])([CH3:87])[CH3:86])[CH2:74][C:75](=[O:81])[O:76][C:77]([CH3:80])([CH3:79])[CH3:78])[CH:68]=[CH:69][N:70]=1)[CH2:52][CH2:53][CH2:54][CH2:55][CH2:56][CH2:57][CH2:58][CH2:59][CH2:60][CH2:61][C:62](O)=[O:63])([CH3:38])([CH3:37])[CH3:36].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C>C(Cl)Cl>[C:85]([O:84][C:83](=[O:89])[CH2:82][N:73]([CH2:74][C:75](=[O:81])[O:76][C:77]([CH3:80])([CH3:79])[CH3:78])[C:72](=[O:90])[CH2:71][N:67]1[CH:68]=[CH:69][N:70]=[C:66]1[CH2:65][N:51]([CH2:50][C:46]1[N:45]([CH2:44][C:43]([N:42]([CH2:92][C:93]([O:94][C:95]([CH3:97])([CH3:96])[CH3:98])=[O:99])[CH2:41][C:40](=[O:100])[O:39][C:35]([CH3:38])([CH3:36])[CH3:37])=[O:91])[CH:49]=[CH:48][N:47]=1)[CH2:52][CH2:53][CH2:54][CH2:55][CH2:56][CH2:57][CH2:58][CH2:59][CH2:60][CH2:61][C:62](=[O:63])[NH:1][CH2:2][CH2:3][CH2:4][CH2:5][C@@H:6]([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[NH:14][C:15](=[O:34])[NH:16][C@H:17]([C:18]([O:20][C:21]([CH3:22])([CH3:23])[CH3:24])=[O:19])[CH2:25][CH2:26][C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])([CH3:86])([CH3:87])[CH3:88]

Participants

7

Procedure

A solution of (S)-di-tert-butyl 2-(3-((S)-6-amino-1-tert-butoxy-1-oxohexan-2-yl)ureido)pentanedioate (85 mg, 0.174 mmol), 11-(bis((1-(2-(bis(2-tert-butoxy-2-oxoethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)amino)undecanoic acid (118 mg, 0.127 mmol), EDCI (38 mg, 0.20 mmol), HOBt (26 mg, 0.20) and DIPEA (0.30 mL) in DCM (5.0 mL) was stirred at rt for overnight. The reaction mixture was purified by biotage eluting with 1% to 10% MeOH in DCM to afford (19S,23S)-tri-tert -butyl 1-(1-(2-(bis(2-tert-butoxy-2-oxoethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(2-tert-butoxy-2-oxoethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-13,21-dioxo-2,14,20,22-tetraazapentacosane-19,23,25-tricarboxylate (38 mg, 21%) as a colorless oil. 1H NMR (400 MHz, CDCl3) 6.95 (d, J=1.2 Hz, 2 H), 6.83 (d, J=0.80 Hz, 2 H), 5.97 (s, 1 H), 5.28 (d, J=7.6 Hz, 1 H), 5.23 (d, J=8.4 Hz, 1 H), 4.94 (s, 4 H), 4.33-4.25 (m, 2H), 4.12 (s, 4 H), 4.03 (s, 4 H), 3.63 (s, 4 H), 3.25-3.16 (m, 2 H), 2.53 (t, J=7.4 Hz, 2 H), 2.33-2.24 (m, 2 H), 2.15 (t, J=7.6 Hz, 2 H), 2.08-2.03 (m, 2 H), 2.02-1.20 (m, 85 H); MS (ESI), 701.6 (M/2+H)+.

Workup

  1. customThe reaction mixture was purified by biotage
  2. washeluting with 1% to 10% MeOH in DCM

Sources & evidence

ORD record
ord-724e3c2498da4c18983dac13d7ce1a07
Source dataset
uspto-grants-2012_07
Patent number
US08211401B2

Reaction notes

Loading…